Intranasal application of vesicular stomatitis virus (VSV) produces a well-characterized model of viral encephalitis in mice. Within one day post-infection (PI), VSV travels to the olfactory bulb and, over the course of 7 days, it infects regions and tracts extending into the brainstem followed by clearance and recovery in most mice by PI day 14 (PI 14). Infectious diseases are commonly accompanied by excessive sleepiness; thus, sleep is considered a component of the acute phase response to infection. In this project, we studied the relationship between sleep and VSV infection using C57BL/6 (B6) and BALB/c mice. Mice were implanted with transmitters for recording EEG, activity and temperature by telemetry. After uninterrupted baseline recordings were collected for 2 days, each animal was infected intranasally with a single low dose of VSV (5 Â 10 4 PFU). Sleep was recorded for 15 consecutive days and analyzed on PI 0, 1, 3, 5, 7, 10, and 14. Compared to baseline, amounts of non-rapid eye movement sleep (NREM) were increased in B6 mice during the dark period of PI 1-5, whereas rapid eye movement sleep (REM) was significantly reduced during the light periods of PI 0-14. In contrast, BALB/c mice showed significantly fewer changes in NREM and REM. These data demonstrate sleep architecture is differentially altered in these mouse strains and suggests that, in B6 mice, VSV can alter sleep before virus progresses into brain regions that control sleep.
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Introduction
Vesicular stomatitis virus (VSV) is a member of the Vesiculovirus genus in the Rhabdoviridae family and it is the prototypic virus of this family that includes rabies virus. The genome of the virus is a single molecule of negative-sense RNA that encodes five major proteins: glycoprotein (G), matrix protein (M), nucleoprotein (N), large protein (L) and phosphoprotein (Kang and Prevec, 1969) . It is a ''simple'' virus that has been well characterized biochemically and immunologically.
Administered intranasally, VSV initially infects and replicates in olfactory receptor neurons and then invades the olfactory bulb (OB) via the olfactory tract and, over the course of 7 days, infects regions and tracts extending into the brainstem. Reiss and colleagues as well as our own more recent studies have extensively characterized this virus encephalitis model induced by a neurotropic viral pathogen. In the VSV encephalitis model, neutrophils are the initial inflammatory cell seen in the OB around 24 hours post-infection (Chen et al., 2001; Blank et al., 2003) , a time when VSV antigens are first detected in this brain region (Huneycutt et al., 1994) . Around PI 6-8, a robust mixed cellular infiltrate dominated by neutrophils, T cells, macrophages and to a lesser extent dendritic cells accumulates in the brain parenchyma (Bi et al., 1995; Ciavarra et al., 2006; Steel et al., 2008 Steel et al., , 2009 . Resident glia cells (astrocytes, microglia) are not quiescent but undergo a rapid and impressive expansion (astrogliosis and microgliosis) following VSV neuroinvasion (Christian et al., 1996) . This acute inflammatory response is temporally associated with peak viral titers at this time (Forger et al., 1991; Reiss et al., 1998) . While intranasal instillation of VSV can result in hind limb paralysis and death (Miyoshi et al., 1971; Rabinowitz et al., 1976; Forger et al., 1991) , mice that survive completely clear VSV from the CNS, an event dependent on T cell-mediated immunity (Forger et al., 1991; Andersson et al., 1994; Soilu-Hanninen et al., 1997; Christensen et al., 2001; Bullard et al., 2005) . Because mice often survive, VSV has become a valuable model for the neurological complications that can persist after transient viral infections of the brain (van den Pol et al., 2002) .
VSV does not produce global infection of the CNS; however, it does course through brain regions that are involved in the regulation of sleep. Major brain structures that show VSV antigen include
